CD8 T cells taken from lesions of vitiligo patients have been shown to kill melanoma cells ex vivo [36], and CD8 T cells from both tumors and peripheral blood of melanoma patients have been shown to kill normal melanocytes [37]. The gene discussed is CD8A; the disease is vitiligo.